Paul W. Schenk

Interpatient variability in the pharmacokinetics of the HIV non‐nucleoside reverse transcriptase inhibitor efavirenz: the effect of gender, race, and <i>CYP2B6</i> polymorphism

David M. Burger, Ilse van der Heiden, Charles la Porte et al. · British Journal of Clinical Pharmacology · 2005 · 211 citations · Full text

Factors Affecting Cytochrome P-450 3A Activity in Cancer Patients

Sharyn D. Baker, Ron H. N. van Schaik, Laurent P. Rivory et al. · Clinical Cancer Research · 2004 · 126 citations · Full text

Cloning and characterisation of the<i>S.pombe rad15</i>gene, a homologue to the<i>S.cerevisiae RAD3</i>and human<i>ERCC2</i>genes

Johanne M. Murray, Claudette L. Doe, Paul W. Schenk et al. · Nucleic Acids Research · 1992 · 79 citations

Resistance to Platinum-Containing Chemotherapy in Testicular Germ Cell Tumors Is Associated with Downregulation of the Protein Kinase SRPK1

Paul W. Schenk, Hans Stoop, Carsten Bokemeyer et al. · Neoplasia · 2004 · 71 citations · Full text

Effect of Common<i>CYP3A4</i>and<i>CYP3A5</i>Variants on the Pharmacokinetics of the Cytochrome<i>P</i>450 3A Phenotyping Probe Midazolam in Cancer Patients

Erin R. Lepper, Sharyn D. Baker, Matt Permenter et al. · Clinical Cancer Research · 2005 · 71 citations · Full text